Telara Pharma S.L. has been created in Madrid (Spain), acquiring a license agreement with Gregorio Marañón Health Research institute (IiSGM), Hospital General Universitario Gregorio Marañón to develop the first kidney-protective drug to prevent and treat the acute renal injury, project that arose from the research of Dr. Alberto Tejedor